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Abstract 
Purpose: To investigate the expressions of toll-like receptor 2 (TLR2), toll-like receptor 4 (TLR4), tumor 
necrosis factor alpha (TNF-α), IFN-γ (IFN- gamma), interleukin 2 (IL-2), interleukin 6 (IL-6) and 
interleukin 10 (IL-10) in human immunodeficiency virus (HIV) patients with tuberculosis (TB) infection.  
Methods: Two groups of HIV patients (68 in each group) were used for this study. These were HIV with 
TB (HIV/TB) group and HIV without TB group. A third group (68 healthy people) served as control. 
Quantitative polymerase chain reaction (qPCR) was adopted to measure TLR-2 and TLR-4 expressions 
in peripheral blood mononuclear cells (PBMC), while the serum levels of TNF-α, IFN-γ, IL-2, IL-6 and IL-
10 were determined by ELISA.  
Results: The △Ct values of TLR-2 and TLR-4 in HIV/TB and HIV groups were significantly lower than 
those in the control group (p < 0.05). Compared to control group, the serum levels of TNF-α, IL-6 and 
IL-10 significantly increased, while IFN-γ and IL-2 in HIV/TB and HIV groups significantly decreased (p < 
0.05). However, IFN-γ and IL-2 decreased significantly in HIV/TB group (p < 0.05). Expression of TLR2 
correlated positively with serum levels of TNF-α, IL-6 and IL-10, but negatively with IFN-γ and IL-2 (p < 
0.05).  
Conclusion: TLR2 signal pathway plays a role in HIV patients with TB infection by promoting the 
expressions of TNF-α, IL-6 and IL-10, while inhibiting IFN-γ and IL-2 cellular factors, and thus may 
provide a new pathway for the treatment of patients with HIV/TB.  
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In recent years, the incidence of HIV with TB 
infection has gradually increased with increasing 
cases of HIV infection. According to statistics, 
one-third of 34 million HIV infected patients 
world-wide have TB [1]. An investigation in South 
Africa showed that about half of 12,672 TB 
patients studied were infected with HIV [2]. HIV 
infection makes patients more susceptible to 
Mycobacterium tuberculosis (MTB) infection, and 
is the most important factor for causing TB. HIV 
infection can damage the human immune 
system, and cause potential TB to become active 
TB. HIV with TB infection is not superimposition 
of independent infectious processes and effects 
of two pathogens. The two are synergistic, 
thereby resulting in deterioration of the disease 
conditions to epidemic proportions. 
  
Toll-like receptors (TLRs) are expressed mainly 
in immune cells, especially in mononuclear cells 
or macrophages, and on the surface of dendritic 
cells. They are a group of very important pattern 
recognition receptors of immunity, which can 
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recognize pathogen-associated molecular 
patterns (PAMPs) and activate in vivo 
inflammatory responses. They are the first line of 
defense in immune reactions [3]. In addition, 
TLRs can induce activation of T-lymphocytes, 
regulate and control adaptive immunity, and 
maintain balance of body immune system [4]. 
Studies have shown that TLR2 and TLR4 
participate in the recognition of TB and 
associated metabolites, and promote 
inflammatory responses against them [5,6]. 
 
The present study was carried out to investigate 
the expressions of TLR2, TLR4, TNF-α, IFN-γ IL-





General information on patients  
 
Sixty-eight (68) HIV cases with TB infection 
(HIV/TB group) in our hospital who were given 
treatment from January, 2014 to December, 
2016, were recruited in this study. They 
consisted of 49 males and 19 females, with ages 
ranging from 19 to 63 years (mean age = 37.82 ± 
8.43 years). The control group was made up of 
68 healthy individuals (50 males and 18 females) 
selected after medical examination. Their ages 
ranged from 20 to 65 years (mean age = 37.46 ± 
8.71 years). Diagnostic standards of HIV 
conformed with the AIDS Diagnostic and 
Treatment Guide, 2011 Edition [7]. Diagnosis of 
TB was in line with the diagnostic standards of 
Diagnostic Criteria for Pulmonary Tuberculosis 
(WS288-2008) by National Health and Family 
Planning Commission of the People’s Republic of 
China [8]. The inclusion criteria in the control 
group were: absence organ diseases of heart, 
brain, lung, autoimmune system and connective 
tissue. In addition, the selected patients were 
those who did not receive immunosuppressant 
drugs or anti-TB treatment within the previous 
year, and those who were free from tumor, 
severe infection, and other immunodeficiency 
diseases. The Medical Ethics Committee of The 
Chest Hospital of Linyi, Shandong Province, 
China approved this study (no. LY2014005), and 
which followed the Helsinki Declaration [9]. All 
subjects agreed to participate in this study and 
signed informed consent. Comparison of 
baseline information between three groups did 
not reveal any significant differences (p > 0.05). 
  
Sample collection  
 
Peripheral blood (10 mL) was collected under 
sterile conditions and divided into two, 5-mL 
portions. To one portion was added 3.8 % 
sodium citrate, and PBMCs was separated by 
Ficoll lymphocyte separation medium (America 
Sigma company). Total RNA in PBMCs was 
extracted with Trizol reagent (America Invitrogen 
company), and cDNA was synthesized by 
reverse transcription (America Promega 
Company). The cDNA was stored at – 20 oC. 
The second 5 mL portion of blood was 
centrifuged at 3000 r/min for 10 min to obtain 
serum which was stored in a fridge at – 20 oC 
prior to analysis.  
 
Biochemical assays  
 
Polymerase chain reaction (qPCR) was used to 
measure the expressions of TLR2 and TLR4 
mRNA. Primer design was synthesized by 
Shanghai Biotechnology. The internal control 
was glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH). The primers used are shown on Table 
1. The 20 μL reaction mixture included 10 μL of 2 
× PCR buffer solution, 0.5 μL of upstream and 
downstream primers, 2 μL of cDNA and 7 μL of 
sterilized distilled water. Reaction conditions: 
pre-degeneration was at 94 oC for 30 s; PCR 
reaction was at 94 oC for 10 s, 60 oC for 20 s, 40 
circles. Curve analysis of solution was at 70~90 
oC /s and reading value was 1s. Gene 
amplification was quantified by using 2-△△ct 
method. The level of TNF-α, IFN-γ, IL-2, IL-6 and 
IL-10 in serum were determined by ELISA kits 
(America R&D Company). 
 
Statistical analysis  
 
SPSS 21.0 software was used to analyze all 
data, and are presented as mean ± standard 
deviation (SD). 
 
      Table 1: Premier sequence and amplification segments of TLR2, TLR4 and GAPDH 
 
Primer Sequence   (bp)  
TLR2-F 5'-CCAAGAGGAAGCCCAAGAAAG-3' 154 
TLR2-R 5'-AAGTCCCGCTTGTGGAGACAC-3'  
TLR4-F 5'-TTGAGCAGGTCTAGGGTGATTGAAC-3' 143 
TLR4-R 5'-ATGCGGACACACACACTTTCAAAT-3'  
GAPDH-F 5-GCACCGTCAAGGCTGAGAAC-3' 138 
GAPDH-R 5'-TGGTGAAGACGCCAGTGGA-3'  
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Comparison between the three groups were 
done by ANOVA. Comparisons between two 
groups were analyzed by t-test. Enumeration 
data were analyzed and compared using χ2 test. 
Correlation analysis between double-variables 
was done by Pearson correlation analysis. P < 





Compared with HIV/TB group, the expressions of 
TLR-2 and TLR-4 mRNA△C values in the control 
group and HIV group were significantly higher (p 
< 0.05). In addition, TLR-4 mRNA△C value in the 
HIV/TB group was significantly lower than that in 
HIV group (p < 0.05). The levels of TLR-4 
mRNA△Ct between the HIV/TB group and HIV 
group showed no significantly differences (p > 
0.05, Table 2).  
 
When compared with the control group, the 
serum levels of TNF-α, IL-6 and IL-10 in HIV/TB 
and HIV groups were significantly increased 
while the levels of IFN-γ and IL-2 decreased 
significantly (p < 0.05). In addition, compared 
with HIV group, the serum levels of TNF-α, IL-6 
and IL-10 in HIV/TB group were significantly 
increased but IFN-γ and IL-2 were significantly 
decreased (p < 0.05, Table 3).  
 
Correlation analysis (Table 4) showed that TLR2 
expression was positively in correlation with the 
levels of TNF-α, IL-6 and IL-10, and negatively 
correlated with the levels of IFN-γ and IL-2 (p < 
0.05). However, the TLR4 expression was no 
obvious correlation with the serum levels of TNF-




CD4+T cells decrease constantly in HIV patients, 
resulting in steady decline in immunity, which 
leads to infections, activation of potential MTB in 
vivo and new TB cases. MTB infection promotes 
HIV viral multiplication thereby aggravating the 
immunodeficiency disease [10]. Thus HIV and 
MTB work synergistically to exacerbate the 
degree of infection and death rate in patients 
who have both conditions [11,12]. In recent 
years, studies on HIV with TB infection have 
increased, and some progress has been made in 
understanding the pathogenesis of this combined 
infection. However, the immune system of HIV 
patients with TB infection is rather complex. At 
present, there are differences in the 
understanding of the pathogenesis of HIV 
complicated with TB infection [13,14]. 
        
Table 2: Expressions of TLR2 and TLR4 mRNA in the three groups (mean ± SD, △Ct values) 
 
Group No. of cases TLR2 mRNA TLR4 mRNA 
Control group  68 2.87±0.80 4.20±0.82 
HIV group  68 2.08±0.61a 3.47±0.78a 
HIV/TB group  68 1.69±0.57ab 3.31±0.72 a 
F-value   55.15 25.52 
P-value   0.00 0.00 
a Compared with the control group (p < 0.05); b compared with the HIV group (p < 0.05) 
 






TNF-α IFN-γ IL-2 IL-6 IL-10 
Control  68 22.54±6.02 38.42±7.15 26.84±7.36 77.62±13.68 0.64±0.17 
HIV  68 41.83±9.64a 27.60±6.31a 19.28±5.52a 172.38±36.84a 2.57±0.67a 
HIV/TB  68 53.13±10.97ab 22.78±6.30ab 14.28±5.37ab 283.82±51.43ab 4.83±0.70ab 
F-value   195.62 100.19 71.88 518.65 927.06 
P-value   0.00 0.00 0.00 0.00 0.00 
a Compared with the control group (p < 0.05); b compared with the HIV group (p < 0.05) 
 
Table 4: Correlations between TLR2, TLR4 expressions and the level of TNF-α, IL-6 and IL-10 in serum 
 
Item  TLR2 mRNA TLR4 mRNA R value P value R value P value 
TNF-α 0.537 0.000 0.203 0.182 
IFN-γ -0.426 0.001 -0.035 0.705 
IL-2 -0.525 0.000 -0.162 0.191 
IL-6 0.648 0.000 0.078 0.484 
IL-10 0.403 0.001 0.154 0.273 
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As pattern-recognition receptors (PRRs) of natal 
immunity, TLRs can recognize PAMPs of 
pathogenic microorganisms, activate congenital 
immune response reaction in innate immune 
response, and also trigger release of immune 
factors [15,16]. The results of this study show 
that the expressions of mRNAs of TLR2 and 
TLR4 in HIV patients with TB, and HIV patients 
without TB, are higher than the corresponding 
expressions in healthy people. This shows that 
HIV infection up-regulates TLR2 and TLR4 
expressions. This finding is in agreement with 
previous reports [17,18]. The TLR-2 mRNA level 
of HIV patients with TB infection was higher 
when compared with its value in the HIV group, 
but there were no differences in TLR4 mRNA 
between the two groups. The HIV virus multiplies 
rapidly and destroys CD4T+ cells constantly, 
thereby weakening the body immunity and 
accelerating the spread of TB infection. The 
expressions of TLR2 and TLR4 have direct 
relationship with HIV viral multiplication. TLR2 
and TLR4 expressions are up-regulated after HIV 
infection. At the same time, high expression of 
TLR2 can promote HIV viral multiplication, but 
TLR4 expression has no such effect [19]. 
Therefore, TLR4 does not have any effects on 
HIV patients with TB, but TLR2 may play a key 
role in these patients. 
 
Balance between Th1 and Th2 cells is important 
for regulation of the immune system. Their 
cellular factors are TNF-α, IFN-γ, IL-2, IL-6 and 
IL-10. Th1 cells induce cellular response reaction 
and inflammatory reaction, but Th2 cell promote 
immunity of body fluids and resist parasitic 
infections; these two types of cells maintain 
balance in the immune system [20]. HIV infection 
affects the levels of Th1 and Th2. When the 
condition of the HIV infected person worsens, it 
causes imbalance in the secretion of Th1 and 
Th2 factors [21,22]. The results of this study 
show that the serum levels of TNF-α, IFN-γ, IL-2, 
IL-6 and IL-10 in HIV patients with TB were 
different from the corresponding levels in HIV 
and the healthy controls. This shows that the 
secretion of TNF-α, IL-6 and IL-10 are closely in 
correlation with HIV and TB infection. The 
analysis showed that in HIV patients with MTB, 
TNF-α, IL-6 and IL-10d were increased, while the 
production of IFN-γ and IL-2 was hindered. Thus 
the body immune function is inhibited, which 
increase susceptibility to MTB.  
 
TLRs cause complex changes which culminate in 
secretion of cellular factors. It is still unclear how 
TLR2 influences HIV and MTB infection. Mehto 
et al [23] reported that MTB and HIV-1 promote 
apoptosis in macrophages through the TLR2 
signal pathway. In addition, Qin et al [24] found 
that the inhibitory immune reaction of TLR2 is 
damaged by inducing over-expression of 
regulatory T-cell (Treg), which causes viral 
infection. In this study, the serum levels of NF-α, 
IFN-γ, IL-2, IL-6 and IL-10 were positively in 
correlation with the expression of TLR2, but not 
with the expression TLR4. This shows that TLR2 
works in a synergistic manner with cellular 
factors, and that the early immune responses 





Overall, the findings of this study have 
demonstrated that TLR2 signal pathway has an 
important impact on HIV and TB infections by 
promoting the expressions of TNF-α, IL-6 and IL-
10 and inhibiting those of IFN-γ and IL-2. The 
results also show that TLR2 is an effective 
inhibitor of HIV-1 multiplication in PBMCs. Thus, 
the findings may be useful in developing new 








Conflict of Interest 
 
No conflict of interest associated with this work. 
 
Contribution of Authors 
 
The authors declare that this work was done by 
the authors named in this article and all liabilities 
pertaining to claims relating to the content of this 
article will be borne by them.  
 
Open Access  
 
This is an Open Access article that uses a fund-
ing model which does not charge readers or their 
institutions for access and distributed under the 
terms of the Creative Commons Attribution 
License (http://creativecommons.org/licenses/by/ 
4.0) and the Budapest Open Access Initiative 
(http://www.budapestopenaccessinitiative.org/rea
d), which permit unrestricted use, distribution, 
and reproduction in any medium, provided the 




1. World Health Organisation. HIV-Associated TB Facts. 
2013. 
Che et al 
Trop J Pharm Res, September 2017; 16(9): 2259  
 
2. Mahtab S, Coetzee D. Influence of HIV and other risk 
factors on tuberculosis. S Afr med J 2017; 107(5): 428-
434. 
3. Kawai T, Akira S. The role of pattern-recognition 
receptors in innate immunity: update on Toll-like 
receptors. Nat Immunol 2010; 11(5): 373-384. 
4. Uto T, Akagi T, Yoshinaga K, Toyama M, Akashi M, Baba 
M. The induction of innate and adaptive immunity by 
biodegradable poly(γ-glutamic acid) nanoparticles via a 
TLR4 and MyD88 signaling pathway. Biomaterials 2011; 
32(22): 5206-5212. 
5. Rahman MA, Sobia P, Gupta N, Kaer LV, Das G. 
Mycobacterium tuberculosis Subverts the TLR-2 - 
MyD88 Pathway to Facilitate Its Translocation into the 
Cytosol. PloS One 2014; 9(1): e86886. 
6. Rocha-Ramírez LM, Estrada-García I, López-Marín LM, 
Segura-Salinas E, Méndez-Aragón P, Van SD, Torres-
González R, Chacón-Salinas R, Estrada-Parra S, 
Maldonado-Bernal C, López-Macías C, Isibasi A. 
Mycobacterium tuberculosis lipids regulate cytokines, 
TLR-2/4 and MHC class II expression in human 
macrophages. Tuberculosis 2008; 88(3): 212-220. 
7. CMA Amgoidbi. AIDS Diagnostic and Treatment, Guide 
2011 Edition. Chin J Infect 2011; 4(10): 321-330. 
8. China MohotPsRo. Diagnostic Criteria for Pulmonary 
Tuberculosis (WS288-2008). Beijing: People’s Medical 
Publishing House 2008: pp 1-16. 
9. Czarkowski M. Helsinki Declaration--next version. Pol 
Merkur Lekarski 2014; 36(215): 295-297. 
10. Cavanaugh J, Genga K, Marigu I, Laserson K, Ackers M, 
Cain K. Tuberculosis among Children in Kenya: 
Epidemiology and Impact of HIV in Two Provinces. J 
Trop Pediatr 2012; 58(4): 292-296. 
11. Getahun H, Gunneberg C, Sculier D, Verster A, 
Raviglione M. Tuberculosis and HIV in people who inject 
drugs: evidence for action for tuberculosis, HIV, prison 
and harm reduction services. Curr Opin in HIV Aids 
2012; 7(4): 345-353. 
12. Xiang-Chan LU, Xue-Qin LI, Ru-Zhi OU, Deng JN, Huang 
AC, Wei-Xin LI, Hong-Zhou LU. Analysis on the risk 
factors of immune reconstitution inflammation syndrome 
after highly active anti-retroviral therapy in AIDS patients 
with tuberculosis infection. Fudan Unive J Med Sci 
2011; 38(5): 436-439. 
13. Xiao-Man LI, Bao FK, Guo MH, Liu AH. Study of the 
pathogenic mechanism of HIV and tuberculosis co-
infection. J Patho Biol 2013;8(5): 469-472. 
14. Koch A, Brites D, Stucki D, Evans JC, Seldon R, Heekes 
A, Mulder N, Nicol M, Oni T, Warner DF. The Influence 
of HIV on The Evolution of Mycobacterium tuberculosis. 
Mol Biol Evol 2017; 34(7) :1654-1668. 
15. Nasr AS, Fawzy SM, Gheita TA, Elkhateeb E. Expression 
of Toll like receptors 3 and 9 in Egyptian systemic lupus 
erythematosus patients. Z für Rheumatol 2016; 75(5): 
502-507. 
16. Si Y, Zhang ZG. Research progress of the roll of Toll-like 
receptors in otitis media. Chin J Otorhinolaryngol Head 
Neck Surg. 2011; 46(9): 780-783. 
17. Su J M HJG, Ye L. Toll-like receptor2 and its signal 
pathway downstream factors expression among HIV 
and M. TB co-infection person. Chin J Infect 2014; 
32(7): 410-413. 
18. Giraldo DM, Hernandez JC, Urcuqui IS. Impact of in vitro 
costimulation with TLR2, TLR4 and TLR9 agonists and 
HIV-1 on antigen-presenting cell activation. Intervirol 
2015; 58(2): 122-129. 
19. Nordone SK, Ignacio GA, Su L, Sempowski GD, 
Golenbock DT, Li L, Dean GA. Failure of TLR4-driven 
NF-kappa B activation to stimulate virus replication in 
models of HIV type 1 activation. Aids Res Hum 
Retroviruses 2007; 23(11): 1387-1395. 
20. Zeng L M LjY, Fen R C. Primary study of Th1 and Th2 
cell function on the process of HIV and PM infection. J 
of Guangxi Medi Univ 2015; 32(4): 626-628. 
21. Hao X B WLX. Advances in the study of dual infection 
with the human immunodeficiency virus and 
mycobacterium tuberculosis. J Patho Bio 2016; 11(4): 
374-376. 
22. Cheng H, Qian YH, Jian-Ru WU. Pathogenic 
mycoplasmas infection and cellular immune function in 
males with HIV infection in Jiangsu province. Chin J 
Public Health 2012;28(12): 1558-1561. 
23. Mehto S, Antony C, Khan N, Arya R, Selvakumar A, 
Tiwari BK, Vashishta M, Singh Y, Jameel S, Natarajan 
K. Mycobacterium tuberculosis and Human 
Immunodeficiency Virus Type 1 Cooperatively Modulate 
Macrophage Apoptosis via Toll Like Receptor 2 and 
Calcium Homeostasis. Plos One 2015; 10(7): e0131767. 
24. Qin X, Yao J, Yang F, Nie J, Wang Y, Liu PC. Human 
immunodeficiency virus type 1 Nef in human monocyte-
like cell line THP-1 expands treg cells via toll-like 
receptor 2. J Cell Biochem 2011; 112(12): 3515-3524. 
 
